Gestational diabetes & diabetes in pregnancy
Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial
An erratum to this article was published (Diabetes Obes Metab, Apr 2026 ↗)
Authors' conclusion
For women with early GDM, despite no improvement in TIR, CGM improved maternal and neonatal outcomes versus SMBG. The effect may be mediated by improved awareness of glycaemic excursions and by facilitation of treatment regimen adjustments.
Study context
- Population
- Women with gestational diabetes mellitus (GDM) diagnosed in gestational weeks 8–26120 completed
- Participants
- 128 women
- Comparison
- Continuous glucose monitoring (CGM) vs routine self-monitoring of blood glucose (SMBG)
- Interventionn = 80
- Controln = 40reference
- Primary endpoint
- TIR 63-140 mg/dL
Methodological details2:1 randomisation, October 2021 to December 2023
- 2:1 randomisation
- October 2021 to December 2023
Primary result
As reported in the abstract
- Between Intervention and Control: P = 0.37
Further findings
Unscheduled caesarean section · V = 0.19
P = 0.046
Preterm delivery · V = 0.19
P = 0.041
Large-for-gestational-age neonates · V = 0.22
P = 0.019
Neonatal ICU admission · V = 0.23
P = 0.013
CGM satisfaction · prior to delivery
- Intervention participants reported high CGM satisfaction and endorsed behavioural and psychosocial benefits
Original publication
Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial. Diabetes Obes Metab. Published 3 November 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →